What Are The Long-Term Effects Of Untreated Myocarditis On Heart Size?
Published on: June 28, 2025
What Are The Long-Term Effects Of Untreated Myocarditis On Heart Size? featured image
  • Article reviewer photo

    Rebecca Houston

    MRes Neuroscience, Newcastle University

  • Article reviewer photo

    Nour Asaad

    MSc Applied Biomolecular Technology, The University of Nottingham

Introduction

Myocarditis is an inflammation of the myocardium, the muscular layer of the heart, often caused by viral infections, bacteria, autoimmune conditions, or toxic substances. It is characterised by the infiltration of inflammatory cells into the heart muscle, which can result in heart muscle damage and impair the heart’s ability to pump blood efficiently. If untreated, myocarditis can lead to serious complications like heart failure, arrhythmias, and even sudden cardiac death.

At the molecular level, myocarditis is typically initiated by viral infections such as enteroviruses, adenoviruses, and parvoviruses, which directly infect cardiomyocytes (heart muscle cells) and trigger an immune response. These viruses can enter the heart cells by binding to specific receptors, causing direct damage and cell breakdown. As the immune system responds to the infection, it activates both the innate and adaptive immune pathways. This immune activation, if excessive, can result in persistent inflammation, further myocardial damage, and remodelling of the heart tissue.1

The immune response to viral infections includes the release of cytokines and chemokines, which exacerbate inflammation and contribute to the recruitment of immune cells like macrophages, monocytes, and T cells to the heart. Persistent inflammation can lead to structural changes in the heart, including ventricular remodelling. Ventricular remodelling refers to changes in the size, shape, and function of the heart’s ventricles, which may lead to a dilated or enlarged heart, commonly known as dilated cardiomyopathy (DCM). This condition weakens the heart and impairs its ability to pump blood effectively, often resulting in heart failure.2 

The molecular biology of myocarditis 

The molecular biology substrate of myocarditis primarily revolves around the inflammatory response that targets the heart’s myocardium, driven by both innate and adaptive immune systems. The process begins when cardiomyocytes (heart muscle cells) are affected by viral infections, autoimmune triggers, or toxic agents, which leads to the activation of immune cells like macrophages, monocytes, and T cells that infiltrate the heart tissue. This infiltration is often driven by the expression of inflammatory cytokines such as TNF-α, IL-6, and IFN-γ, which regulate the local immune response and enhance inflammation.3

As myocarditis progresses, electrical remodelling along with inflammation, leads to structural changes in the heart, such as ventricular dilation and fibrosis. This can evolve into dilated cardiomyopathy (DCM), where the heart muscle becomes enlarged and weakened, impairing its ability to pump blood effectively. Chronic inflammation and disrupted ion transport mechanisms play a central role in this process. The combination of these molecular changes underpins both the functional and structural remodelling seen in myocarditis, ultimately contributing to heart failure if left untreated.1

The cell biology of myocarditis revolves around the immune system's response to infection or injury in the heart. Myocarditis typically begins with viral entry into cardiomyocytes, leading to cell damage and activating immune responses. The following are key cellular events involved.

Cardiomyocyte infection

Viruses such as coxsackievirus and adenovirus can enter cardiomyocytes, causing direct damage. Viral replication inside these cells leads to the release of new viral particles and triggers cell death (apoptosis or necrosis), initiating a successive inflammatory sequence.

Innate immune response

The first responders are cells of the innate immune system, including macrophages, neutrophils, and dendritic cells. These cells recognise the presence of viral components or cell damage through pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs). Infected or damaged cardiomyocytes release alarmins (like IL-1β) and damage-associated molecular patterns (DAMPs), which further recruit immune cells to the heart.4 

Monocyte and macrophage infiltration

Monocytes, recruited from the bone marrow and spleen, infiltrate the myocardium and turn into macrophages. Macrophages secrete cytokines like TNF-α and IL-6, contributing to ongoing inflammation and tissue damage. This cellular infiltration and “cytokine storm” exacerbate the inflammatory response, leading to tissue remodelling.

T and B cell activation

During the adaptive immune response, CD4+ T helper cells and CD8+ cytotoxic T cells are activated. These T cells can directly kill infected cardiomyocytes or perpetuate inflammation through the release of cytokines. B cells contribute by producing autoantibodies against cardiac antigens, which can further damage heart tissue.4

Cardiac fibroblast activation

Fibroblasts (cells that assist the formation of connective tissue) in the myocardium become activated in response to injury, contributing to the development of fibrosis. This scar tissue replaces damaged cardiomyocytes, reducing the heart's contractile function and contributing to ventricular remodelling.5 

Chronic inflammation and remodelling

Prolonged inflammation leads to persistent recruitment of immune cells and sustained production of cytokines, resulting in chronic myocardial damage and fibrosis. Over time, this process can lead to ventricular dilation, thinning of the heart walls, and impaired heart function, which characterises dilated cardiomyopathy.

Associated changes in heart size 

Untreated myocarditis can lead to significant structural changes in the heart, primarily due to persistent inflammation, cellular damage, and the body's immune response. These structural changes include ventricular remodelling, which often results in an enlargement of the heart (DCM) and changes in the thickness of the ventricular walls. 

In myocarditis, the inflammatory process damages the heart muscle (myocardium), leading to a cycle of injury and repair. The infiltration of immune cells, such as monocytes and lymphocytes, into the myocardium, causes direct cell damage and fibrosis. As the body attempts to heal this damage, fibrotic tissue replaces healthy myocardial cells, which reduces the heart's ability to contract properly. The reduction in contractility increases the volume of blood left in the ventricles after each heartbeat, leading to increased ventricular pressure and wall stress.

This stress prompts further changes, including ventricular dilatation, which means the heart chambers expand to compensate for reduced pumping efficiency. This dilatation eventually leads to heart failure if left untreated, as the heart becomes less capable of maintaining proper circulation due to weakened muscles and the continuous remodelling process.6

Summary

Myocarditis is inflammation of the heart muscle, often caused by viral infections, bacteria, autoimmune conditions, or harmful substances. This leads to inflammation in the heart, which can damage the heart muscle and affect its ability to pump blood. If not treated, myocarditis can cause severe issues like heart failure, irregular heartbeats, or sudden cardiac death. The condition usually starts with viral infections such as enteroviruses, adenoviruses, and parvoviruses that infect heart muscle cells. This infection prompts the immune system to react, which can cause excessive inflammation and further damage to the heart. The immune response consists of cytokines and chemokines that draw immune cells to the heart, causing structural changes like ventricular remodelling. This remodelling can lead to dilated cardiomyopathy (DCM), a condition where the heart becomes enlarged and weak, reducing its ability to pump blood efficiently. The molecular biology of myocarditis centres on the inflammatory response that affects the heart muscle. Over time, chronic inflammation can induce changes in the heart's structure and function, resulting in heart failure if left untreated. As the condition progresses, cardiac fibroblasts form scar tissue, reducing heart function and contributing to chronic inflammation. Untreated myocarditis leads to ongoing damage and heart enlargement, ultimately resulting in heart failure due to dysfunction in pumping blood.

FAQs

Can you live a long life with myocarditis?

After treatment, many patients live long, full lives free from the effects of myocarditis.

Can your heart go back to normal after myocarditis?

Myocarditis may occur abruptly (acutely), can happen multiple times, or may persist over a longer period (chronic). The majority of individuals will recuperate without enduring consequences.

What happens if myocarditis is left untreated?

Myocarditis may harm the heart muscle, impairing its ability to effectively pump blood.

What should you do to avoid myocarditis?

Avoid eating foods that contain high levels of sodium, as well as those rich in saturated and trans fats. Stay away from caffeinated beverages and energy drinks, as they can increase your heart rate, making it strain more and hindering its healing process.

References

  1. Tschöpe C, Ammirati E, Bozkurt B, Caforio ALP, Cooper LT, Felix SB, et al. Myocarditis and inflammatory cardiomyopathy: current evidence and future directions. Nature Reviews Cardiology [Internet]. 2020 Oct 12;18(3):169–93. Available from: https://doi.org/10.1038/s41569-020-00435-x.
  2. Wakisaka Y, Niwano S, Niwano H, Saito J, Yoshida T, Hirasawa S, et al. Structural and electrical ventricular remodelling in rat acute myocarditis and subsequent heart failure. Cardiovascular Research [Internet]. 2004 May 29;63(4):689–99. Available from: https://doi.org/10.1016/j.cardiores.2004.04.020.
  3. Tian M, Yuan YC, Li JY, Gionfriddo MR, Huang RC. Tumor necrosis factor-α and its role as a mediator in myocardial infarction: A brief review. Chronic Diseases and Translational Medicine. 2015;1(1): 18–26. https://doi.org/10.1016/j.cdtm.2015.02.002. 
  4. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P. Innate immunity [Internet]. Molecular Biology of the Cell - NCBI Bookshelf. 2002. Available from: https://www.ncbi.nlm.nih.gov/books/NBK26846/#:~:text=Summary,present%20in%20the%20uninfected%20host. 
  5. Hall C, Gehmlich K, Denning C, Pavlovic D. Complex relationship between cardiac fibroblasts and cardiomyocytes in health and disease. Journal of the American Heart Association [Internet]. 2021 Feb 15;10(5). Available from: https://doi.org/10.1161/jaha.120.019338.
  6. Fukuta H, Little WC. The cardiac cycle and the physiologic basis of left ventricular contraction, ejection, relaxation, and filling. Heart Failure Clinics [Internet]. 2008 Jan 1;4(1):1–11. Available from: https://doi.org/10.1016/j.hfc.2007.10.004.
Share

Oana-Maria Popa

BSc (Hons), Biomedical Sciences, University of Leeds

arrow-right